lipohypertrophy
Jump to navigation
Jump to search
Etiology
Pathology
Clinical manifestations
- occurs at injection site of repeated insulin injections
- palpable, rubbery growth
- hyperpigmentation uncommon
Adverse effects
- labile control of blood glucose levels due to variable insulin absorption
Management
More general terms
References
- ↑ Verma R Images in Clinical Medicine. Insulin-Mediated Lipohypertrophy N Engl J Med 2017; 377:573. August 10, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28792866 Free full text <Internet> http://www.nejm.org/doi/full/10.1056/NEJMicm1701235?